The company outlines a clear development path that begins with consultation, moves into sample testing, then transitions into manufacturing and packaging, and finally continues with marketing support and professional training
Not a Cosmetic Drug: While weight loss can have cosmetic benefits, semaglutide is primarily a medication for managing medical conditions like type 2 diabetes and obesity
ATTAIN-2 (NCT05872620) is a Phase 3, 72-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of Foundayo 5.5 mg, 9 mg or 17.2 mg as monotherapy with placebo in adults with obesity or overweight and type 2 diabetes
Why would we discontinue providing a benefit that has proven to be a big effect on health outcomes overall for the general population? said Rita Bartolacci, Benefits Strategist, Healthcare and Well-Being
BB-DP, bio breeding diabetes-prone
Based on clinical experience, sleep-related issues, when they occur, are often transient and tend to improve as the body adjusts to the medication
